DCI Indonesia Tbk vs Prodia Diagnostic Line Tbk — how do they compare? DCI Indonesia Tbk trades at Rp206,000 (market cap 491.05T), while Prodia Diagnostic Line Tbk trades at Rp262 (market cap 470.58B, 9.88M 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 1043.5× Prodia Diagnostic Line Tbk's market cap. Which is the better fit depends on your goals.
| DCII | PRDL | |
|---|---|---|
Market Cap | 491.05T | 470.58B |
Volume | — | 9.88M |
Lot | — | 98.85K |
Turnover | — | 2.6B |
Average Price | — | 263.04 |
Value | — | 2.6B |
Indicative Equilibrium Price | — | 272 |
Indicative Equilibrium Volume | — | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →